Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CNSX:ATT NYSE:MYI NYSE:TAM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATTAbattis BioceuticalsC$0.00C$0.05▼C$0.74N/AN/A1.42 million shsN/AMYIBlackRock MuniYield Quality Fund III$10.46-0.9%$10.43$9.98▼$12.07N/A0.57188,163 shs147,589 shsTAM(TAM)$0.00$18.95▼$26.96N/AN/A330,661 shsN/A5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATTAbattis Bioceuticals0.00%0.00%0.00%0.00%0.00%MYIBlackRock MuniYield Quality Fund III-0.62%-0.24%+0.87%-1.23%-9.16%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/AN/AN/AMYIBlackRock MuniYield Quality Fund IIIN/AN/AN/AN/AN/AN/AN/AN/ATAM(TAM)N/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATTAbattis Bioceuticals 0.00N/AN/AN/AMYIBlackRock MuniYield Quality Fund III 0.00N/AN/AN/ATAM(TAM) 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/AMYIBlackRock MuniYield Quality Fund IIIN/AN/AN/AN/AN/AN/ATAM(TAM)N/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATTAbattis BioceuticalsN/AN/A0.00N/AN/AN/AN/AN/AN/AMYIBlackRock MuniYield Quality Fund IIIN/AN/A0.00∞N/AN/AN/AN/A10/1/2025 (Estimated)TAM(TAM)N/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthATTAbattis BioceuticalsN/AN/AN/AN/AN/AMYIBlackRock MuniYield Quality Fund III$0.444.21%N/AN/AN/ATAM(TAM)N/AN/AN/AN/AN/ALatest TAM, ATT, MYI, and N91 DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/5/2025MYIBlackRock MuniYield Quality Fund IIImonthly$0.05556.4%8/15/20258/15/20259/2/20257/3/2025MYIBlackRock MuniYield Quality Fund IIImonthly$0.05556.3%7/15/20257/15/20258/1/20256/4/2025MYIBlackRock MuniYield Quality Fund IIImonthly$0.05556.4%6/13/20256/13/20257/1/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATTAbattis BioceuticalsN/AMYIBlackRock MuniYield Quality Fund III34.01%TAM(TAM)N/AInsider OwnershipCompanyInsider OwnershipATTAbattis BioceuticalsN/AMYIBlackRock MuniYield Quality Fund III1.00%TAM(TAM)N/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATTAbattis BioceuticalsN/AN/AN/ANot OptionableMYIBlackRock MuniYield Quality Fund III147,000N/AN/ANot OptionableTAM(TAM)N/AN/AN/ANot OptionableTAM, ATT, MYI, and N91 HeadlinesRecent News About These Companies2 SF restaurants closed due to cockroach infestations5 hours ago | msn.comSaffola Owner Marico MD Says Food Biz May Become Bigger Than Edible Oil in 3-4 YearsAugust 16 at 8:09 AM | outlookbusiness.comOTam Jai International Announces Effective Date of Privatization SchemeAugust 15 at 4:56 PM | msn.comSpecial dinner celebrates Yunnan's prized wild mushroomsAugust 15 at 6:34 AM | chinadaily.com.cnCTam Jai International Announces Court-Sanctioned Scheme and Delisting PlanAugust 13 at 2:24 PM | msn.comImmunobiology of the TAM receptors - Nature Reviews ImmunologyAugust 12, 2025 | nature.comNPark Tam-hee opened her mouth to rumors of divorce A fellow actor also asks if you really have a husbandAugust 12, 2025 | msn.comBCB appoints Alex Marshall as ACU consultant, introduces Mymensingh as first-class tamAugust 10, 2025 | theprint.inTTrying Tam’s Burgers for the FIRST TIME!!August 8, 2025 | msn.comFood & Beverages emerges as the leading sector with 22% share of ad volumes: TAM ReportAugust 8, 2025 | exchange4media.comETAM remains resilient with diversificationAugust 8, 2025 | aircargonews.netAFood & beverage leads with 22% share as India’s TV ads dip 10%: TAM reportAugust 8, 2025 | socialsamosa.comSJovita Tam: How to Stop Playing AI Games and Start Building Real Strategic CapabilitiesAugust 7, 2025 | msn.comThomas Muller’s $685K MLS Salary Is Just the Start — Massive Pay Bump Coming in 2026August 2, 2025 | athlonsports.comAPumping up the jam: Five questions with Tam JacowayJuly 28, 2025 | msn.comDick Spotswood: Tam District plan to help Black students is good compromiseJuly 28, 2025 | marinij.comMMt. Tam railroad's last survivor restored and ready for new role at California museumJuly 28, 2025 | msn.comCitigroup Raises Nvidia (NVDA) Target on Soaring AI Chip DemandJuly 26, 2025 | msn.comIndex Ventures’ Jahanvi Sardana shares the truth about TAM and what founders should focus on insteadJuly 25, 2025 | msn.comTam’s Cafe taste test and pop-up this Saturday at NaKornJuly 23, 2025 | evanstonroundtable.comENew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesD-Wave, SuperQ, and Verge: A New Path Forward for Quantum?By Nathan Reiff | July 28, 20253 Stocks With Monopoly Power—and Minimal CompetitionBy Gabriel Osorio-Mazilli | August 10, 2025The 4 Dividend Stocks Smart Money Is Grabbing Right NowBy Thomas Hughes | July 24, 2025Big 3 Telecom Wars: 2 Solid Showings, 1 Huge Winner in Q2By Leo Miller | July 29, 2025Why Options Traders Are Betting Big on Oracle Stock By Gabriel Osorio-Mazilli | July 24, 2025TAM, ATT, MYI, and N91 Company DescriptionsAbattis Bioceuticals CNSX:ATTAbattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.BlackRock MuniYield Quality Fund III NYSE:MYI$10.46 -0.09 (-0.85%) Closing price 08/15/2025 03:58 PM EasternExtended Trading$10.48 +0.02 (+0.24%) As of 08/15/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BlackRock MuniYield Quality Fund III, Inc. is a closed ended fixed income mutual fund launched by BlackRock, Inc. It is managed by BlackRock Advisors, LLC. The fund invests in fixed income markets. It invests primarily in a portfolio of long-term investment-grade municipal obligations exempt from federal income taxes. BlackRock MuniYield Quality Fund III, Inc. was formed in April 13, 1992 and is domiciled in United States.(TAM) NYSE:TAMTaminco Corp is a producer of alkylamines and alkylamine derivatives. The Company's products are used by its customers in the manufacturing of everyday products primarily for the agriculture, water treatment, personal and home care, animal nutrition and oil and gas end-markets. It operates in 19 countries with seven production facilities and, as of December 31, 2012, had an installed production capacity of 1,272 thousand tons. The Company has three business segments: Functional Amines, Specialty Amines, and Crop Protection. In March 2014, the Company announced that it completed the acquisition of the formic acid business of Kemira Oyj. Its main shareholder is Eastman Chemical Company. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Applied Materials' Knee-Jerk Sell-Off Is Your Signal to Buy Buffett’s Mystery Buy Revealed, and It’s a Big Bet on UNH AI Glasses to Replace Smartphones? Meta Is Taking Aim at Apple Deere’s Sell-Off Could Be a Long-Term Buying Chance 3 Restaurant Stocks That Will Outperform in Q3 and Q4 Cisco Systems: The Only AI Stock Income Investors Need to Own Gartner’s RSI Just Sank to 11: That’s a Setup You Can’t Ignore The Real Reason Ford Stock Is Rallying—Can It Keep Going? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access